John Kao/JEK Trust sells large ALHC blocks under 10b5-1 (ALHC)
Rhea-AI Filing Summary
Alignment Healthcare, Inc. reports proposed sales of Common Stock by affiliated holders via Form 144, listing multiple planned dispositions executed under a 10b5-1 sales plan and RSU vesting events. The filing lists specific transactions including 12/29/2025 sale of 605,648 shares ($11,351,466.51) and earlier 180,000-share sales on 01/12/2026, 02/10/2026, and 03/10/2026 under the 10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021. It also records RSU vesting acquisitions of 82,500 shares on 03/13/2024 and 91,398 shares on 03/13/2025.
Positive
- None.
Negative
- None.
Insights
Form 144 lists affiliate dispositions under a prearranged 10b5-1 plan and recent RSU vesting.
These entries show multiple large sales attributed to the JEK Trust and John Kao, with a cluster of 180,000-share transactions in 01/12/2026, 02/10/2026, and 03/10/2026, plus a 605,648-share sale on 12/29/2025 for $11,351,466.51. The filing explicitly references a 10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021.
These are routine affiliate disposition notices rather than operational disclosures. The listed RSU vesting events on 03/13/2024 (82,500 shares) and 03/13/2025 (91,398 shares) document acquisition dates for shares that were later available for sale. Subsequent filings or trading reports would be required to quantify total insider ownership changes or replacement of float.
FAQ
What large transactions are reported in the ALHC Form 144 excerpt?
Are the sales tied to a trading plan in the ALHC filing?
What dates show the clustered sales activity in the filing?